Chronic myelomonocytic leukemia: A rare hematologic malignancy that needs due consideration
Archives of Hematology Case Reports and Reviews · 2020
DOI: 10.17352/ahcrr.000026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Hematology Case Reports and Reviews, 2020. Verfasst von Assefa Temesgen und 1 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Chronic Myelomonocytic Leukemia (CMML) is a malignant hematopoietic stem cell disorder with clinical and pathological features of both a myeloproliferative neoplasm and myelodysplastic syndrome [1].
Zitieren
APA
Temesgen, A., & Yosef, A. (2020). Chronic myelomonocytic leukemia: A rare hematologic malignancy that needs due consideration. Archives of Hematology Case Reports and Reviews. https://doi.org/10.17352/ahcrr.000026
Vancouver
Temesgen A, Yosef A. Chronic myelomonocytic leukemia: A rare hematologic malignancy that needs due consideration. Archives of Hematology Case Reports and Reviews. 2020. doi:10.17352/ahcrr.000026
BibTeX
@article{Temesgen2020,
author = {Temesgen, Assefa and Yosef, Alebel},
title = {Chronic myelomonocytic leukemia: A rare hematologic malignancy that needs due consideration},
journal = {Archives of Hematology Case Reports and Reviews},
year = {2020},
doi = {10.17352/ahcrr.000026}
}
EUVIMED